论文信息 - First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. - 字舞流文

First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.

E. Plimack | R. Walgren | R. Cohen | Takami Sato | C. Denlinger | N. Lewis | J. Wallin | B. Moser | A. He | Wei Zhang | A. Birnbaum | J. Giles | A. Sama | M. Mynderse | J. Hwang | Michele Niland